| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/30/1997 | WO1997003192A2 Chromosome 1 gene and gene products related to alzheimer's disease |
| 01/30/1997 | WO1997003191A1 Novel factor viii:c polypeptide analogs comprising factor v domains or subdomains |
| 01/30/1997 | WO1997003190A1 HUMAN GALECTIN-4-LIKE PROTEIN AND cDNA ENCODING THE SAME |
| 01/30/1997 | WO1997003188A2 Use of mp52 or mp121 for treating and preventing diseases of the nervous system |
| 01/30/1997 | WO1997003094A1 Cell adhesion inhibitors |
| 01/30/1997 | WO1997003093A1 Peptide derivatives and angiotensin iv receptor agonist |
| 01/30/1997 | WO1997003087A1 Novel regulatory genes |
| 01/30/1997 | WO1997003086A1 Early onset alzheimer's disease gene and gene products |
| 01/30/1997 | WO1997003085A1 Intracellular action of nucleic acid ligands |
| 01/30/1997 | WO1997003055A1 Compounds, compositions, and methods for inhibiting replication of retroviruses and for inhibiting tumor promoter initiated transcription |
| 01/30/1997 | WO1997002841A1 Genetic therapy employing the hhv-6a derived ts gene or polypeptide |
| 01/30/1997 | WO1997002839A1 Viral suppression, treatment and prevention of viral infections |
| 01/30/1997 | WO1997002837A1 Method of treating rheumatoid arthritis with low dose type ii collagen |
| 01/30/1997 | WO1997002834A1 Analogs of parathyroid hormone |
| 01/30/1997 | WO1997002833A1 A stabilized pharmaceutical formulation comprising a growth hormone and a peptide comprising at least, one basic amino acid residue and at least one acid amino acid residue |
| 01/30/1997 | WO1997002832A1 Lyophilized hgf preparations |
| 01/30/1997 | WO1997002810A2 Polymeric lamellar substrate particles for drug delivery |
| 01/30/1997 | WO1997002730A2 Enamel matrix related polypeptide |
| 01/30/1997 | WO1996041815A3 CONJUGATES OF αMSH WITH A FATTY ACID, PREPARATION METHOD THEREFOR, AND USE THEREOF AS A DRUG |
| 01/30/1997 | WO1996041607A3 Pharmaceutical compositions comprising restrictin p/activin a and use thereof as antagonist of il-6 and/or il-11 |
| 01/30/1997 | WO1996040745A3 Amino acid amides of 5-amino-1,3,4-thiadiazones and their use as inhibitors for matrix metalloproteinases |
| 01/30/1997 | WO1996040739A3 Urethane mediated, gst specific molecular release systems |
| 01/30/1997 | WO1996039523A3 Bacterial production of hydrophobic polypeptides |
| 01/30/1997 | WO1996039429A3 Serum protein produced exclusively in adipocytes |
| 01/30/1997 | WO1996039425A3 Compounds having bradykinin antagonistic activity and mu-opioid agonistic activity |
| 01/30/1997 | WO1996039423A3 A method for increasing the electrotransport flux of polypeptides |
| 01/30/1997 | WO1996038555A3 Unc-53 from c. elegans and its uses in testing compounds involved in the control fo cell behaviour and pharmaceutical compositions |
| 01/30/1997 | WO1996035805A3 Tripeptidylpeptidase inhibitors |
| 01/30/1997 | DE19527552A1 Transketolase-verwandtes-Protein Transketolase-related protein |
| 01/30/1997 | CA2235718A1 Method of treating rheumatoid arthritis with low dose type ii collagen |
| 01/30/1997 | CA2226868A1 Cell adhesion inhibitors |
| 01/30/1997 | CA2226658A1 Early onset alzheimer's disease gene and gene products |
| 01/30/1997 | CA2226570A1 Enamel matrix related polypeptide |
| 01/30/1997 | CA2226553A1 A stabilized pharmaceutical formulation comprising a growth hormone and a peptide comprising at least, one basic amino acid residue and at least one acid amino acid residue |
| 01/30/1997 | CA2226303A1 Peptide derivatives and angiotensin iv receptor agonist |
| 01/30/1997 | CA2226255A1 Chromosome 1 gene and gene products related to alzheimer's disease |
| 01/30/1997 | CA2223884A1 Polymeric lamellar substrate particles for drug delivery |
| 01/30/1997 | CA2223645A1 Antisense inhibition of hepatitis b virus replication |
| 01/29/1997 | EP0756010A2 Method for detecting, identifying, and quantitating organisms and viruses |
| 01/29/1997 | EP0756006A2 Nucleotide sequence of the mycoplasma genitalium genome, fragments thereof, and uses thereof |
| 01/29/1997 | EP0756005A1 Gene coding for adseverins |
| 01/29/1997 | EP0755942A1 Peptide derivative |
| 01/29/1997 | EP0755684A1 Vaccine conjugate |
| 01/29/1997 | EP0755683A1 Immunotherapy of tumor with monoclonal antibody against the 17-1A antigen |
| 01/29/1997 | EP0755682A1 Methods of treatment of motor neuron diseases using members of the BDNF/NT-3/NGF family of molecules |
| 01/29/1997 | EP0755454A1 Aav-mediated delivery of dna to cells of the nervous system |
| 01/29/1997 | EP0755452A1 Method and composition for regulating apoptosis |
| 01/29/1997 | EP0755451A1 Materials and methods for management of hyperacute rejection in human xenotransplantation |
| 01/29/1997 | EP0755450A1 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE |
| 01/29/1997 | EP0755446A1 Cardiotrophin and uses therefor |
| 01/29/1997 | EP0755445A1 Cell-cycle regulatory proteins, and uses related thereto |
| 01/29/1997 | EP0755443A1 Tissue-specific enhancer active in prostate |
| 01/29/1997 | EP0755439A1 Process for producing dendritic cells, cells thus produced and container for carrying out this process |
| 01/29/1997 | EP0755408A1 Peptides for reducing or inhibiting bone resorption, angiogenesis and restenosis |
| 01/29/1997 | EP0755407A1 Pharmaceutical peptide formulations for treatment of dust mite allergy |
| 01/29/1997 | EP0755406A1 Method and product for regulating cell responsiveness to external signals |
| 01/29/1997 | EP0755405A1 Phosphonyldipeptides useful in the treatment of cardiovascular diseases |
| 01/29/1997 | EP0755404A1 Tachykinin antagonists |
| 01/29/1997 | EP0755383A1 Inhibitors of farnesyl-protein transferase |
| 01/29/1997 | EP0755270A1 Microcapsules, method of making and their use |
| 01/29/1997 | EP0755268A1 Compositions and methods for gene therapy to treat disease |
| 01/29/1997 | EP0755266A1 An adjuvant |
| 01/29/1997 | EP0755265A1 The combination of growth hormone and insulin-like growth factor, for treating congestive heart failure |
| 01/29/1997 | EP0755264A1 Treatment of congestive heart failure |
| 01/29/1997 | EP0755263A1 Compositions and methods for stimulating megakaryocyte growth and differentiation |
| 01/29/1997 | EP0755262A1 Composition for the treatment of lung disease |
| 01/29/1997 | EP0755261A1 Bandage for continuous application of biologicals |
| 01/29/1997 | EP0755259A1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON |
| 01/29/1997 | EP0755258A1 Methods of treating disease using sertoli cells and allografts or xenografts |
| 01/29/1997 | EP0755257A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection |
| 01/29/1997 | EP0723453A4 Method of treating reproductive disorders |
| 01/29/1997 | EP0708671A4 Drug delivery |
| 01/29/1997 | EP0693119B1 Needleless syringe using supersonic gas flow for particle delivery |
| 01/29/1997 | EP0673256A4 Suppression of myeloid cells. |
| 01/29/1997 | EP0653990B1 Timing valve for the discontinuous metering of a volume flow |
| 01/29/1997 | EP0644772A4 Opioid peptides. |
| 01/29/1997 | EP0604605A4 Treating disorders by application of insulin-like growth factors and analogs. |
| 01/29/1997 | EP0493446B1 Treatment of autoimmune disease |
| 01/29/1997 | CN1141651A Endothelin-converting enzyme (ECE) |
| 01/29/1997 | CN1141650A Macroencapsulated secretory cells |
| 01/29/1997 | CN1141637A Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 01/29/1997 | CN1141593A Medical apptication of bromelain |
| 01/29/1997 | CN1141592A Pharmaceutical prepn. contg. plasminogen activators |
| 01/29/1997 | CN1141591A Method for reproducing in vitro the proteolytic activity of the NS3 protease of hepatitis C virus (HCV) |
| 01/29/1997 | CN1141196A Application of quinoxalines in combination with protease inhibitors as medicaments |
| 01/29/1997 | CN1141195A Zinc chelate prostate extract, the mfg. method and application thereof |
| 01/28/1997 | US5597946 Method for introduction of disease and pest resistance into plants and novel genes incorporated into plants which code therefor |
| 01/28/1997 | US5597945 Plants genetically enhanced for disease resistance |
| 01/28/1997 | US5597928 Retroviral protease inhibiting compounds |
| 01/28/1997 | US5597927 Retroviral protease inhibiting compounds |
| 01/28/1997 | US5597926 Retroviral protease inhibiting compounds |
| 01/28/1997 | US5597901 Homogeneous human interleukin 2 |
| 01/28/1997 | US5597900 Crystalline interleukin-4 |
| 01/28/1997 | US5597899 Tumor necrosis factor muteins |
| 01/28/1997 | US5597898 NF-κB activation regulatory protein, IκB-β |
| 01/28/1997 | US5597897 Polymer matrix made from lactic acid and/or glycolic acid for sequestering proteins |
| 01/28/1997 | US5597896 Retrovirus human immunodeficiency virus type 2(HIV2), capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes |
| 01/28/1997 | US5597895 Inhibiting the expression of hiv virus |
| 01/28/1997 | US5597894 Multi-tyrosinated somatostatin analogs |
| 01/28/1997 | US5597825 Aggregation inhibitors |